# Suresh Anne, M.D. – FDA Inspection, Feb 13, 2026

Source: https://www.keypedia.com/records/fda_inspections/suresh-anne-md/702db3e3-c90d-4154-a9af-af832180260c
Source feed: FDA_Inspections

> FDA inspection 1302630 of Suresh Anne, M.D., February 13, 2026. 2 citations under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302630
- Company Name: Suresh Anne, M.D.
- Inspection Date: 2026-02-13
- Project Area: Bioresearch Monitoring: Human Drugs
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Detroit District Office
- Citation Count: 2

## Related Documents

- [FDA Inspection 1205635 - 2023-05-19](https://www.keypedia.com/records/fda_inspections/suresh-anne-md/0e93834a-f706-4113-b82c-e9796d856b90)

## Related Officers

- [Company Rep](https://www.keypedia.com/people/dina-a-tallman/e9bf2b98-6697-4d7c-9052-84339536acfd)
- [Issuing Officer](https://www.keypedia.com/people/victoria-r-flournoy/f8bdf401-7e11-4706-9d36-d8eab4fe46ff)

Company: https://www.keypedia.com/companies/suresh-anne-md/224b7a49-5956-463a-85ec-097c5b1d8fac

Office: https://www.keypedia.com/offices/detroit-district-office/b09a1815-a000-40c0-bb44-5432ce87ed03
